Influencing Public Policy on Research and Clinical Endocrinology

Society Letters

The Endocrine Society produces and signs onto a range of letters to elected officials, Federal agencies, and other legislative and deliberative bodies.  

  • Endocrine Society Opposes the Use of Prevention and Public Health Funds to Offset Spending in the Puerto Rico Economic Empowerment Act
    June 18, 2018 | The Endocrine Society joined 65 other groups in signing a letter addressed to Senators Marco Rubio and Orrin Hatch to express opposition to using Prevention and Public Health Funds for purposes unintended under the original authorization. The Endocrine Society recognizes the need to provide economic support to Puerto Rico in the aftermath of last year's devastating hurricane season, but does not believe it should come at the expense of critical public health funding.
  • Endocrine Society Expresses Concerns Over Resolution Limiting Surgeries in Infants with DSD
    June 15, 2018 | The Endocrine Society and the Pediatric Endocrine Society co-wrote a letter to California state Senators Scott Wiener, Steve Glazer, and Monique Limón expressing concerns over resolution SCR-110 that would restrict parents’ rights to make decisions regarding surgery for infants born with Differences in Sex Development. Our organizations believe that nuanced, scientific, and evidence-based decision making that is currently part of the process is not reflected in the bill, and therefore does not adequately address the needs of constituencies.
  • Friends of the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD): June 12, 2018 | Friends of the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) requests $39.3 billion for the National Institutes of Health for fiscal year 2019, with a proportional increase in funding for a total of $1.531 billion for NICHD.
  • Endocrine Society Concerned Proposed EPA Transparency Rule Will Restrict Ability to Develop and Implement Effective Restrictions on Hazardous Chemicals
    May 21, 2018 | While the Endocrine Society supports appropriate public access to data and methodology for independent validation, the proposed rule is unclear and difficult to describe operationally. We are therefore concerned that the proposed regulation will restrict the ability of the EPA to develop and implement effective restrictions on hazardous chemicals. As such, this rule would increase the potential for human health harms due to chemical exposures.
  • Endocrine Society Opposes Proposed Change to National Crime Victimization Survey Related to Gender Identity
    May 11, 2018 | The notice proposes to raise the minimum age at which National Crime Victimization Survey questions are administered on sexual orientation and gender identity from age 16 to 18. The Endocrine Society is concerned that the proposed changes to information collection will result in the loss of data on an important subset of the transgender community and provide an incomplete picture of crimes committed against this population. We urge the Administration to continue to collect information on gender identity and sexual orientation from individuals 16 years of age and older.
  • Endocrine Society Supports J Code for Growth Hormone Stimulation Testing Agent MACRILEN
    Mary 10, 2018 | The Society sent a letter to the Centers for Medicare and Medicaid Services (CMS), showing support for their proposal to develop a J Code for MACRILEN. The FDA-approved oral agent can diagnose Adult Growth Hormone Deficiency (AGHD) without an injection.
  • Endocrine Society Recommends Removal of Medication-Related Products from Tariffs Proposed Rule
    May 9, 2018 | The Endocrine Society opposes the application of an additional 25 percent tariff on medications, raw materials used in the production of medications, and medical devices. The Society is concerned that additional tariffs will lead to a shortage of medications as the manufacturers identify alternative sources that are less expensive or an increase in price that could make the cost untenable.
  • Endocrine Society Identifies Improvements to EPA's Strategic Plan to Promote Alternative Test Methods
    April 26, 2018 | The Society recommends that that the alternative methods evaluated by the EPA should be able to predict effects on the endocrine system in a rigorous, transparent manner that avoids conflicts of interest. We also recommend that alternative methods should include academic research and academic scientists, and that time frames and goals should be realistic.
  • Friends of NIEHS Sign-On Letter in Support of the Superfund Research Program
    April 18, 2018 | This letter requests an increase to the Superfund Research Program appropriation of $3 million in the Interior and Environment Appropriations Bill for fiscal year 2019 to a total of $80 million. The letter was organized by the Friends of the National Institute of Environmental Health Sciences.

See all...

Society Testimony

Representing the Endocrine Society, our members strive to influence public policy related to research and clinical endocrinology issues by testifying before the United States Congress, Federal agencies, and other legislative and deliberative bodies.

See all...